Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHuKFG for Steroid Refractory GI aGvHD
NCT00038792Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2000
- Primary completion
- Jan 2003
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of palifermin in acute gastrointestinal graft-versus-host disease (aGI-GVHD), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2000; status: terminated.
02
Drugs
palifermin
03
Conditions
acute gastrointestinal graft-versus-host disease (aGI-GVHD)
Beyond the preview
Go deeper on NCT00038792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038792.